Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 976270, 8 pages
http://dx.doi.org/10.1155/2013/976270
Research Article

Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action

1Department of Oriental Gynecology, College of Korean Medicine, Kyung Hee University, No. 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea
2Department of Oriental Pharmaceutical Science and Kyung Hee East-West Pharmaceutical Research Institute, College of Pharmacy, Kyung Hee University, No. 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea

Received 30 March 2013; Revised 30 July 2013; Accepted 31 July 2013

Academic Editor: Chang Shik Yin

Copyright © 2013 Deok-Sang Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Paulus and K. Jellinger, “The neuropathologic basis of different clinical subgroups of Parkinson's disease,” Journal of Neuropathology and Experimental Neurology, vol. 50, no. 6, pp. 743–755, 1991. View at Google Scholar · View at Scopus
  2. P. Jenner, H. Hunot, O. Olanow et al., “Oxidative stress in Parkinson's disease,” Annals of Neurology, vol. 53, supplement 3, pp. S26–S38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. Schapira, “Mitochondria in the aetiology and pathogenesis of Parkinson's disease,” The Lancet Neurology, vol. 7, no. 1, pp. 97–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. W. Olanow and W. G. Tatton, “Etiology and pathogenesis of Parkinson's disease,” Annual Review of Neuroscience, vol. 22, pp. 123–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Orth and A. H. V. Schapira, “Mitochondria and degenerative disorders,” American Journal of Medical Genetics, vol. 106, no. 1, pp. 27–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, “Molecular pathophysiology of Parkinson's disease,” Annual Review of Neuroscience, vol. 28, pp. 57–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Halbach, A. Schober, and K. Krieglstein, “Genes, proteins, and neurotoxins involved in Parkinson's disease,” Progress in Neurobiology, vol. 73, no. 3, pp. 151–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Boka, P. Anglade, D. Wallach, F. Javoy-Agid, Y. Agid, and E. C. Hirsch, “Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease,” Neuroscience Letters, vol. 172, no. 1-2, pp. 151–154, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Nagatsu, M. Mogi, H. Ichinose, and A. Togari, “Cytokines in Parkinson's disease,” Journal of Neural Transmission, Supplement, vol. 58, pp. 143–151, 2000. View at Google Scholar · View at Scopus
  10. L. Qian, P. M. Flood, and J. Hong, “Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy,” Journal of Neural Transmission, vol. 117, no. 8, pp. 971–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. C. Hirsch and S. Hunot, “Neuroinflammation in Parkinson's disease: a target for neuroprotection?” The Lancet Neurology, vol. 8, no. 4, pp. 382–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Usuki, E. Kotani, Y. Kawakura, M. Sano, Y. Katsura, and T. Kubo, “Tokishakuyakusan effect on DNA polymerase alpha activity in relationship to DNA synthesis before and/or after the LH/FSH surge in rats,” The American Journal of Chinese Medicine, vol. 23, no. 3-4, pp. 231–242, 1995. View at Google Scholar · View at Scopus
  13. T. Akase, T. Akase, S. Onodera et al., “A comparative study of the usefulness of Toki-shakuyaku-san and an oral iron preparation in the treatment of hypochromic anemia in cases of uterine myoma,” Yakugaku Zasshi, vol. 123, no. 9, pp. 817–824, 2003. View at Google Scholar · View at Scopus
  14. H. Takei, Y. Nakai, N. Hattori et al., “The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by N ω-nitro-L-arginine methyl ester,” Phytomedicine, vol. 11, no. 1, pp. 43–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Usuki and E. Kotani, “Tokishakuyakusan directly attenuates PACAP's luteolytic action on luteal function in the rat ovary,” American Journal of Chinese Medicine, vol. 30, no. 4, pp. 521–531, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Park, J. Yang, and D. Kim, “A clinical trial to verity the quality of life improvement efficacy of Dangguijakyak-san and Gyejibongnyeong-hwan granulation in postmenopausal women,” The Journal of Oriental Obstetrics and Gynecology, vol. 20, pp. 213–228, 2007. View at Google Scholar
  17. M. Ito, M. Ohbayashi, M. Furukawa, and S. Okoyama, “Neuroprotective effects of TJ-23 (Tokishakuyakusan) on adult rat motoneurons following peripheral facial nerve axotomy,” Otolaryngology, vol. 136, no. 2, pp. 225–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Itoh, S. Michijiri, S. Murai et al., “Regulatory effect of danggui-shaoyao-san on central cholinergic nervous system dysfunction in mice,” American Journal of Chinese Medicine, vol. 24, no. 3-4, pp. 205–217, 1996. View at Google Scholar · View at Scopus
  19. N. Egashira, K. Iwasaki, Y. Akiyoshi et al., “Protective effect of Toki-shakuyaku-san on amyloid β25–35-induced neuronal damage in cultured rat cortical neurons,” Phytotherapy Research, vol. 19, no. 5, pp. 450–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kou, D. Zhu, and Y. Yan, “Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice,” Journal of Ethnopharmacology, vol. 97, no. 2, pp. 313–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Qian, H. Wang, W. Yao, and X. Gao, “Aqueous extract of the Chinese medicine, Danggui-Shaoyao-San, inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade,” Cell Biology International, vol. 32, no. 2, pp. 304–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Hwang, H. G. Kim, H. Kwon et al., “Dangguijakyak-san, a medicinal herbal formula, protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 934–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Lee, D. Hwang, H. G. Kim, C. Lee, and M. S. Oh, “Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions,” Journal of Ethnopharmacology, vol. 139, no. 3, pp. 883–888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Delgado and D. Ganea, “Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation,” The FASEB Journal, vol. 17, no. 8, pp. 944–946, 2003. View at Google Scholar · View at Scopus
  25. G. T. Liberatore, V. Jackson-Lewis, S. Vukosavic et al., “Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease,” Nature Medicine, vol. 5, no. 12, pp. 1403–1409, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Hu, D. Zhang, H. Pang et al., “Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease,” Journal of Immunology, vol. 181, no. 10, pp. 7194–7204, 2008. View at Google Scholar · View at Scopus
  27. M. F. Beal, “Mitochondria, oxidative damage, and inflammation in Parkinson's disease,” Annals of the New York Academy of Sciences, vol. 991, pp. 120–131, 2006. View at Google Scholar · View at Scopus
  28. R. Mosley, E. J. Benner, I. Kadiu et al., “Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease,” Clinical Neuroscience Research, vol. 6, no. 5, pp. 261–281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Moncada and J. P. Bolaños, “Nitric oxide, cell bioenergetics and neurodegeneration,” Journal of Neurochemistry, vol. 97, no. 6, pp. 1676–1689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Sedelis, K. Hofele, G. W. Auburger, S. Morgan, J. P. Huston, and R. K. W. Schwarting, “MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences,” Behavior Genetics, vol. 30, no. 3, pp. 171–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. G. E. Meredith and U. J. Kang, “Behavioral models of Parkinson's disease in rodents: a new look at an old problem,” Movement Disorders, vol. 21, no. 10, pp. 1595–1606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Matsuura, H. Kabuto, H. Makino, and N. Ogawa, “Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion,” The Journal of Neuroscience Methods, vol. 73, no. 1, pp. 45–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Sakai, Y. Irie, T. Murata, A. Ishige, N. Anjiki, and K. Watanabe, “Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice,” Phytotherapy Research, vol. 21, no. 9, pp. 868–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Lan, J. Liu, L. Chen et al., “Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 386–395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Liu, T. Tzeng, S. Liou, and C. J. Chang, “Beneficial effect of traditional chinese medicinal formula Danggui-Shaoyao-San on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 140103, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. D. C. Wu, V. Jackson-Lewis, M. Vila et al., “Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease,” The Journal of Neuroscience, vol. 22, no. 5, pp. 1763–1771, 2002. View at Google Scholar · View at Scopus
  37. P. S. Whitton, “Inflammation as a causative factor in the aetiology of Parkinson's disease,” British Journal of Pharmacology, vol. 150, no. 8, pp. 963–976, 2007. View at Publisher · View at Google Scholar · View at Scopus